RishiPuriMD

Interventional Cardiology, Preventive Cardiology

Physician

Dr. Puri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment Start of enrollment: 2023 Oct 05
Enrolling by invitation
Roles: Principal Investigator, Contact

PubMed

2 citations
Transcatheter Left Ventricular Reconstruction in Heart Failure Patients With Prior Anterior Myocardial Infarction: The Prospective ALIVE Trial.
Jerry D Estep, Ori Ben-Yehuda, Andrew S Wechsler, Rishi Puri, Andrew C Kao
JACC. Heart Failure. 2025-02-01
Outcomes and Predictors of Different Flow-Gradient Patterns of Aortic Stenosis After Transcatheter Aortic Valve Replacement.
Besir Besir, Shivabalan Kathavarayan Ramu, Maryam Muhammad Ali Majeed-SAidan, Judah Rajendran, Odette Iskandar
The American Journal of Cardiology. 2025-01-23
Elastic Recoil and Deployment Asymmetry of the Transcatheter Heart Valve in Bicuspid Versus Tricuspid Anatomy.
Odette Iskandar, Habib Layoun, Shivabalan Kathavarayan Ramu, Judah Rajendran Ravi Raja Malar Vannan, Elian Abou Asala
Catheterization and Cardiovascular Interventions. 2025-01-22

Journal Articles

Original Investigation Effect of Evolocumab on Coronary Plaque Composition
Steven E Nissen, Ransi Somaratne, Rishi Puri, Christie M Ballantyne, ScienceDirect
Editorial Comment Unraveling the Cardiovascular PROSPECTs of Patients with Prediabetes∗
Rishi Puri, MD, ScienceDirect

Lectures

C-Reactive Protein Levels Modulate Lipoprotein(a)-Associated Cardiovascular Risk in Optimally-Treated Patients With High-Risk Vascular Disease
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Some Guidance for Managing Patients with AS and CAD: ReviewDecember 24th, 2024
NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients with Significant CADSeptember 1st, 2024
BioVentrix Raises $48.5m for Transcatheter Ventricular Enhancement System PMAApril 14th, 2023
Join now to see all